287 related articles for article (PubMed ID: 14613973)
21. Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity.
Chellaiah A; Yuan W; Chellaiah M; Ornitz DM
J Biol Chem; 1999 Dec; 274(49):34785-94. PubMed ID: 10574949
[TBL] [Abstract][Full Text] [Related]
22. A familial case of Muenke syndrome. Diverse expressivity of the FGFR3 Pro252Arg mutation--case report and review of the literature.
Aravidis C; Konialis CP; Pangalos CG; Kosmaidou Z
J Matern Fetal Neonatal Med; 2014 Sep; 27(14):1502-6. PubMed ID: 24168007
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor receptors, developmental corruption and malignant disease.
Kelleher FC; O'Sullivan H; Smyth E; McDermott R; Viterbo A
Carcinogenesis; 2013 Oct; 34(10):2198-205. PubMed ID: 23880303
[TBL] [Abstract][Full Text] [Related]
24. Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis.
Rannan-Eliya SV; Taylor IB; De Heer IM; Van Den Ouweland AM; Wall SA; Wilkie AO
Hum Genet; 2004 Aug; 115(3):200-7. PubMed ID: 15241680
[TBL] [Abstract][Full Text] [Related]
25. Molecular diagnosis of bilateral coronal synostosis.
Mulliken JB; Steinberger D; Kunze S; Müller U
Plast Reconstr Surg; 1999 Nov; 104(6):1603-15. PubMed ID: 10541159
[TBL] [Abstract][Full Text] [Related]
26. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
[TBL] [Abstract][Full Text] [Related]
27. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.
Yeh BK; Igarashi M; Eliseenkova AV; Plotnikov AN; Sher I; Ron D; Aaronson SA; Mohammadi M
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2266-71. PubMed ID: 12591959
[TBL] [Abstract][Full Text] [Related]
28. Hearing loss in syndromic craniosynostoses: introduction and consideration of mechanisms.
Agochukwu NB; Solomon BD; Muenke M
Am J Audiol; 2014 Jun; 23(2):135-41. PubMed ID: 24686979
[TBL] [Abstract][Full Text] [Related]
29. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.
Muenke M; Schell U; Hehr A; Robin NH; Losken HW; Schinzel A; Pulleyn LJ; Rutland P; Reardon W; Malcolm S
Nat Genet; 1994 Nov; 8(3):269-74. PubMed ID: 7874169
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetics of craniosynostotic syndromes.
Müller U; Steinberger D; Kunze S
Graefes Arch Clin Exp Ophthalmol; 1997 Sep; 235(9):545-50. PubMed ID: 9342602
[TBL] [Abstract][Full Text] [Related]
31. Mutation detection in FGFR2 craniosynostosis syndromes.
Hollway GE; Suthers GK; Haan EA; Thompson E; David DJ; Gecz J; Mulley JC
Hum Genet; 1997 Feb; 99(2):251-5. PubMed ID: 9048930
[TBL] [Abstract][Full Text] [Related]
32. Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1.
Beenken A; Eliseenkova AV; Ibrahimi OA; Olsen SK; Mohammadi M
J Biol Chem; 2012 Jan; 287(5):3067-78. PubMed ID: 22057274
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic diversity in patients with craniosynostoses unrelated to Apert syndrome: the role of fibroblast growth factor receptor gene mutations.
Ito S; Sekido K; Kanno H; Sato H; Tanaka M; Yamaguchi K; Yamamoto I
J Neurosurg; 2005 Jan; 102(1 Suppl):23-30. PubMed ID: 16206730
[TBL] [Abstract][Full Text] [Related]
34. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity.
Olsen SK; Ibrahimi OA; Raucci A; Zhang F; Eliseenkova AV; Yayon A; Basilico C; Linhardt RJ; Schlessinger J; Mohammadi M
Proc Natl Acad Sci U S A; 2004 Jan; 101(4):935-40. PubMed ID: 14732692
[TBL] [Abstract][Full Text] [Related]
35. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
Vajo Z; Francomano CA; Wilkin DJ
Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
[TBL] [Abstract][Full Text] [Related]
36. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.
Galvin BD; Hart KC; Meyer AN; Webster MK; Donoghue DJ
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7894-9. PubMed ID: 8755573
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
38. FGFR-associated craniosynostosis syndromes and gastrointestinal defects.
Hibberd CE; Bowdin S; Arudchelvan Y; Forrest CR; Brakora KA; Marcucio RS; Gong SG
Am J Med Genet A; 2016 Dec; 170(12):3215-3221. PubMed ID: 27481450
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
Ignelzi MA; Wang W; Young AT
J Bone Miner Res; 2003 Apr; 18(4):751-9. PubMed ID: 12674336
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor receptor mutations and craniosynostosis: three receptors, five syndromes.
Wilkie AO
Indian J Pediatr; 1996; 63(3):351-6. PubMed ID: 10830010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
